Overactive bladder syndrome. other specified disorders of bladder
Conditions
Interventions
Intervention 1: Intervention group gives 60mg diltiazem oral tablet twice daily for one month. Intervention 2: Control group gives 2mg tolterodine oral tablet twice daily for one month.
Treatment - Drugs
Intervention group gives 60mg diltiazem oral tablet twice daily for one month.
Control group gives 2mg tolterodine oral tablet twice daily for one month.
Sponsors
Vice chancellor for research, kermanshah university of medical science
Eligibility
Sex/Gender
Male
Age
65 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients between 65 to 85 years old; with the history of prostatectomy in Emamreza Hospital; suffering OAB; agreement for enter to study. Exclusion criteria: Having systolic blood pressure under 90; bradicardia; congestive heart failure; bladder cancer; history of bladder radiation; interavesical BCG therapy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients symptoms of OAB. Timepoint: First of trial and one month later. Method of measurement: Questions of patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: First of trial and one month later. Method of measurement: Questions from patients.;Blood pressure. Timepoint: First of trial and one month later. Method of measurement: Blood pressure measurement mmhg. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAkbar Heidaripoor
Kermanshah university of medical science
Outcome results
None listed